Mesoblast Ltd (MSB) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.027x

Based on the latest financial reports, Mesoblast Ltd (MSB) has a cash flow conversion efficiency ratio of -0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-15.56 Million ≈ $-11.01 Million USD) by net assets (AU$574.68 Million ≈ $406.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Mesoblast Ltd net asset quality index to measure how much of total assets are equity-financed.

Mesoblast Ltd - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Mesoblast Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Mesoblast Ltd (MSB) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Mesoblast Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mesoblast Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
ADMA Biologics Inc NASDAQ:ADMA	0.149x
Intapp Inc NASDAQ:INTA	0.028x
Newell Rubbermaid Inc. NASDAQ:NWL	0.067x
Shenyang Machine Tool Co Ltd SHE:000410	0.062x
Compania Nationala de Transport al Energiei Electrice Transelectrica SA RO:TEL	0.054x
Zhejiang HangKe Technology Co Ltd SHG:688006	-0.018x
Stock Yards Bancorp Inc NASDAQ:SYBT	0.051x
Elang Mahkota Teknologi Tbk JK:EMTK	-0.013x

Annual Cash Flow Conversion Efficiency for Mesoblast Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Mesoblast Ltd from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Mesoblast Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$597.44 Million ≈ $422.73 Million	AU$-49.95 Million ≈ $-35.35 Million	-0.084x	+17.12%
2024-06-30	AU$480.36 Million ≈ $339.88 Million	AU$-48.46 Million ≈ $-34.29 Million	-0.101x	+19.98%
2023-06-30	AU$501.84 Million ≈ $355.08 Million	AU$-63.27 Million ≈ $-44.77 Million	-0.126x	+4.74%
2022-06-30	AU$497.04 Million ≈ $351.69 Million	AU$-65.78 Million ≈ $-46.54 Million	-0.132x	+27.87%
2021-06-30	AU$581.40 Million ≈ $411.38 Million	AU$-106.68 Million ≈ $-75.48 Million	-0.183x	-78.83%
2020-06-30	AU$549.33 Million ≈ $388.68 Million	AU$-56.37 Million ≈ $-39.88 Million	-0.103x	+14.59%
2019-06-30	AU$481.05 Million ≈ $340.37 Million	AU$-57.79 Million ≈ $-40.89 Million	-0.120x	+12.56%
2018-06-30	AU$546.01 Million ≈ $386.34 Million	AU$-75.01 Million ≈ $-53.08 Million	-0.137x	+25.64%
2017-06-30	AU$516.77 Million ≈ $365.64 Million	AU$-95.47 Million ≈ $-67.55 Million	-0.185x	-10.89%
2016-06-30	AU$528.16 Million ≈ $373.71 Million	AU$-88.00 Million ≈ $-62.26 Million	-0.167x	+16.58%
2015-06-30	AU$609.36 Million ≈ $431.16 Million	AU$-121.71 Million ≈ $-86.12 Million	-0.200x	-39.49%
2014-06-30	AU$571.72 Million ≈ $404.53 Million	AU$-81.86 Million ≈ $-57.92 Million	-0.143x	-66.87%
2013-06-30	AU$630.27 Million ≈ $445.95 Million	AU$-54.08 Million ≈ $-38.27 Million	-0.086x	+43.03%
2012-06-30	AU$478.85 Million ≈ $338.82 Million	AU$-72.12 Million ≈ $-51.03 Million	-0.151x	-171.78%
2011-06-30	AU$515.84 Million ≈ $364.99 Million	AU$108.23 Million ≈ $76.58 Million	0.210x	+182.38%
2010-06-30	AU$37.92 Million ≈ $26.83 Million	AU$-9.66 Million ≈ $-6.83 Million	-0.255x	+28.89%
2009-06-30	AU$25.79 Million ≈ $18.25 Million	AU$-9.24 Million ≈ $-6.54 Million	-0.358x	-51.39%
2008-06-30	AU$26.22 Million ≈ $18.55 Million	AU$-6.20 Million ≈ $-4.39 Million	-0.237x	+46.61%
2007-06-30	AU$20.54 Million ≈ $14.53 Million	AU$-9.10 Million ≈ $-6.44 Million	-0.443x	-66.55%
2006-06-30	AU$11.97 Million ≈ $8.47 Million	AU$-3.18 Million ≈ $-2.25 Million	-0.266x	-747.50%
2005-06-30	AU$19.26 Million ≈ $13.63 Million	AU$-604.81K ≈ $-427.94K	-0.031x	--

About Mesoblast Ltd

AU:MSB Australia Biotechnology

Market Cap

$1.90 Billion

AU$2.69 Billion AUD

Market Cap Rank

#6290 Global

#153 in Australia

Share Price

AU$2.08

Change (1 day)

+2.46%

52-Week Range

AU$1.89 - AU$3.07

All Time High

AU$5.21